Msn - Profile
✉ Email this page to a colleague
Drugs and US Patents for Msn
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Msn | SILDENAFIL CITRATE | sildenafil citrate | FOR SUSPENSION;ORAL | 214641-001 | Feb 8, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Msn | CARMUSTINE | carmustine | INJECTABLE;INJECTION | 214814-001 | May 11, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Msn | BORTEZOMIB | bortezomib | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | 209622-001 | Jul 26, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Msn | OLMESARTAN MEDOXOMIL | olmesartan medoxomil | TABLET;ORAL | 217399-003 | Jan 18, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Msn Labs Pvt Ltd | LACOSAMIDE | lacosamide | TABLET;ORAL | 204921-001 | Mar 17, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Msn | OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | CAPSULE;ORAL | 212544-001 | May 20, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Msn | OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | CAPSULE;ORAL | 212544-002 | May 20, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
